A placebo-controlled, patient and investigator blinded, randomized parallel cohort study to assess pharmacodynamics, pharmacokinetics, safety, tolerability and preliminary clinical efficacy of VAY736 and CFZ533 in patients with systemic lupus erythematosus (SLE)

Project: Other

Project Description

NMA HREC Reference Number: HREC/43150/MonH-2018-151243
NMA SSA Reference Number: SSA/43150/MonH-2018-158186
Monash Health Ref: RES-18-0000-513A
SEO Code: 920116 Skeletal System and Disorders (incl. Arthritis)
StatusActive
Effective start/end date5/12/184/12/23